The benefits emerged early and continued to accrue through the trial, with no suggestion of attenuation during up to 5 years of treatment.
The antianginal was unable to provide added benefit when added to optimal medical therapy, but one expert questions: Was the right population studied?
The document takes a paradigm shift away from the conventional classification of AF and goes all in on measuring quality of care, including patient-reported outcomes.
"We have numerous examples in the literature and in our own experience that COVID-19 is accompanied by either another virus or another bacterial infection, including influenza."
Patients can be tested in the first 2 weeks, but a negative antibody test does not rule out COVID-19, an expert panel finds in newly released...
These are the coronavirus stories you need to know about today.
Increased rates of poor mental health, as well as research into a link between depression and coronavirus involvement in the central nervous system, resulted in this...
N95 masks that are well past their expiration date or have been used and re-sterilized are acceptable alternatives to standard new single-use N95 masks, a new...
The program's director also said any vaccine will go through a full FDA approval process.
In the US, where at least 4.6 million people have been infected and nearly 155,000 have died, the promise of that vaccine is hampered by a...